# Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis

> **NCT00883636** · — · TERMINATED · sponsor: **Northwell Health** · enrollment: 4 (actual)

## Conditions studied

- Focal Segmental Glomerulosclerosis
- Nephrotic Syndrome
- Steroid Resistant Nephrotic Syndrome
- Chronic Kidney Disease

## Interventions

- **OTHER:** Cardiovascular Assessment
- **OTHER:** Renal Assessment
- **OTHER:** Genetic Evaluation

## Key facts

- **NCT ID:** NCT00883636
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** study stopped due to lack of activity
- **Last updated:** 2013-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883636, "Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00883636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*